IRadimed

IRMD · NASDAQ

$88.24+$0.59 (+0.67%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $87.65

Latest news

Press releaseJul 31, 8:15 AM ETGlobe Newswire
IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
NewsJul 10, 8:14 AM ETShomik Sen Bhattacharjee
Elon Musk Confirms Starlink Can Deliver Reliable 10 Gigabit-a-Second Upload and Download Speeds Anywhere On Earth
NewsMay 1, 8:31 AM ET
iRadimed Q1 Adj. EPS $0.49 Beats $0.45 Estimate, Sales $21.979M Beat $21.315M Estimate
Press releaseMay 1, 8:30 AM ETGlobe Newswire
IRADIMED CORPORATION Reports First Quarter 2026 Financial Results
NewsMay 1, 7:11 AM ET
Earnings Scheduled For May 1, 2026
NewsFeb 10, 10:56 AM ETAvi Kapoor
Datadog, Spotify, Marriott, Ferrari And Other Big Stocks Moving Higher On Tuesday
NewsFeb 10, 8:02 AM ET
iRadimed Q4 Earnings Summary & Key Takeaways
Press releaseFeb 10, 8:00 AM ETGlobe Newswire
IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share
NewsFeb 10, 6:11 AM ET
Earnings Scheduled For February 10, 2026
NewsFeb 9, 3:02 PM ET
Uncovering Potential: iRadimed's Earnings Preview
Press releaseDec 8, 8:30 AM ETGlobe Newswire
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
Press releaseNov 3, 8:30 AM ETGlobe Newswire
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results
Press releaseSep 2, 8:00 AM ETGlobe Newswire
IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director
Press releaseAug 26, 4:05 PM ETGlobe Newswire
IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference
Press releaseAug 1, 8:30 AM ETGlobe Newswire
IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results
Press releaseMay 29, 8:30 AM ETGlobe Newswire
IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System
Press releaseMay 5, 7:00 AM ETGlobe Newswire
IRADIMED CORPORATION Announces First Quarter 2025 Financial Results
Press releaseFeb 13, 8:30 AM ETGlobe Newswire
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share
Press releaseDec 19, 8:30 AM ETGlobe Newswire
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Press releaseDec 10, 8:30 AM ETGlobe Newswire
IRADIMED CORPORATION on Forbes' List of America's Most Successful Small-Cap Companies for 2025

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

Elon Musk Confirms Starlink Can Deliver Reliable 10 Gigabit-a-Second Upload and Download Speeds Anywhere On Earth

iRadimed Q1 Adj. EPS $0.49 Beats $0.45 Estimate, Sales $21.979M Beat $21.315M Estimate

IRADIMED CORPORATION Reports First Quarter 2026 Financial Results

Earnings Scheduled For May 1, 2026

Datadog, Spotify, Marriott, Ferrari And Other Big Stocks Moving Higher On Tuesday

iRadimed Q4 Earnings Summary & Key Takeaways

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

Earnings Scheduled For February 10, 2026

Uncovering Potential: iRadimed's Earnings Preview

IRADIMED Announces Special Cash Dividend of $0.50 Per Share

IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results

IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director

IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference

IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results

IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System

IRADIMED CORPORATION Announces First Quarter 2025 Financial Results

IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share

IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference

IRADIMED CORPORATION on Forbes' List of America's Most Successful Small-Cap Companies for 2025